NL-OMON39252RecruitingNot Applicable
Heart failure in children with cardiomyopathy. Which markers can be used to predict outcome? - Cardiomyopathy in children
Erasmus MC, Universitair Medisch Centrum Rotterdam0 sites120 target enrollmentStarted: TBDLast updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Recruiting
- Enrollment
- 120
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 2 to 17 (—)
Inclusion Criteria
- •Children with dilated cardiomyopathy
Exclusion Criteria
- •inabilty to cooperate with the study protocol (i.e mental retardation)
- •For specific procedures within the protocol general accepted contra-indications may apply. Specifiically, for MRI the presence of MRI incompatible materials in the body and for the application of contrast because of renal impairment.
Investigators
Similar Trials
Completed
Not Applicable
exploratory study for children severe cardiomyopathy using YS0001Severe Cardiomyopathy in Pediatric patietnsJPRN-UMIN000015893Department of Cardiovascular Surgery, Graduate School of medicine, Osaka University3
Completed
Not Applicable
Cardiovascular function in children with heart failure with preserved ejection fractioJPRN-UMIN000010821Saitama Medical Center, Saitama Medical School40
Unknown
Not Applicable
Classification of Heart Failure in ChildrenHeart FailureNCT03451097Assiut University50
Not yet recruiting
Not Applicable
Cardiomyopathy and heart failure risk after treatment for Hodgkin lymphoma or aggressive B cell non-Hodgkin lymphomaHeartfailure1002532310019280cardiomyopathyNL-OMON50135ederlands Kanker Instituut800
Completed
Not Applicable
Cardiac Biomarkers in Pediatric Cardiomyopathy (PCM Biomarkers)Dilated CardiomyopathyHypertrophic CardiomyopathyNCT01873976Wayne State University288